Literature DB >> 805737

Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies.

J L Gollan, S N Huang, B Billing, S Sherlock.   

Abstract

Three brothers with severe type 2 Crigler-Najjar syndrome for over 50 years have been studied. Although the plasma unconjugated bilirubin (UCB) concentrations were in excess of 19 mg per 100 ml, no abnormal neurological signs were evident. Prolonged exposure to severe unconjugated hyperbilirubinemia does not therefore necessarily increase morbidity. Electron microscopy of liver tissue obtained from 2 patients before phenobarbital therapy showed hypertrophy and hyperplasia of smooth endoplasmic reticulum with unusual prominence of the Golgi apparatus and focal modification of the cell surface membranes. These changes may reflect the reactive state of the hepatocyte to high levels of unconjugated bilirubin. Phenobarbital therapy resulted in a marked reduction in UCB concentration and was accompanied by further hypertrophy of the smooth endoplasmic reticulum and minor changes in bile canaliculi. Dietary restriction to 400 cal daily for 3 days produced a dramatic increase in UCB. The addition of 2400 cal by the intravenous administration of 50% dextrose did not reduce the elevated UCB. In contrast, 2400 cal fed as a normal diet rapidly returned the UCB to basal levels. While on phenobarbital therapy, a similar response to caloric withdrawal and parenteral feeding was observed. These findings indicate that the hyperbilirubinemia of fasting does not depend on caloric deficiency per se, and suggest that either the route of caloric administration or the type of nutrient may influence the level of unconjugated hyperbilirubinemia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 805737

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndrome.

Authors:  J L Gollan; C Bateman; B H Billing
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

Review 2.  New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias.

Authors:  P Berthelot; D Dhumeaux
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

3.  Gilbert's syndrome: evidence of morphological heterogeneity.

Authors:  J Dawson; D L Carr-Locke; I C Talbot; F D Rosenthal
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

4.  Pediatric gastroenterology 1/1/69-12/31/75: a review. Part II. The liver and biliary tract.

Authors:  A Finley; M Andorsky; M Davidson
Journal:  Am J Dig Dis       Date:  1977-02

Review 5.  New insights in bilirubin metabolism and their clinical implications.

Authors:  Eva Sticova; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

6.  Crigler-Najjar type II disease inheritance: a family study.

Authors:  P Labrune; A Myara; C Hennion; J P Gout; F Trivin; M Odievre
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  The use of jejunal transplants to treat a genetic enzyme deficiency.

Authors:  B M Jaffe; A A Burgos; M Martinez-Noack
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

8.  Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.

Authors:  B W Trotman; L Shaw; J Roy-Chowdhury; P F Malet; E F Rosato
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

9.  Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease.

Authors:  J Fevery; N Blanckaert; K P Heirwegh; A M Préaux; P Berthelot
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

10.  Crigler-Najjar syndrome type II. New observation of possible autosomal recessive inheritance.

Authors:  S Güldütuna; U Langenbeck; K W Bock; A Sieg; U Leuschner
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.